Testosterone injections and gels can both treat appropriately diagnosed testosterone deficiency, but they require different routines and precautions. The choice involves the exact formulation, medical history, household contact, comfort with injections, access, and follow-up testing. Neither route is universally better, and doses cannot be converted by comparing the numbers printed on two labels. This guide explains practical questions to discuss with a prescriber, with particular attention to testosterone cypionate injections and topical testosterone gel.
Confirm the diagnosis before comparing delivery methods
The first question is whether testosterone treatment is appropriate. Guidelines require compatible symptoms or signs and consistently low testosterone levels, followed by evaluation of the cause. A convenient injection schedule or an appealing topical routine does not establish a treatment indication. The Endocrine Society guideline describes the diagnostic and safety assessment.
Fertility plans also belong before route selection. Both injected and topical external testosterone can suppress sperm production. Changing from one to the other does not reliably preserve fertility. Our testing guide and fertility guide explain these preliminary decisions. Once treatment is supported, the clinician can compare formulations that fit the individual’s health and daily circumstances.
Injectable testosterone is a category, not one product
Injectable products differ in testosterone ester, concentration, carrier ingredients, route, release pattern, and dosing schedule. Testosterone cypionate, enanthate, and undecanoate should not be treated as interchangeable names for the same prescription. The label and instructions for the actual product matter.
The cited Depo-Testosterone product contains testosterone cypionate and is labeled for intramuscular injection. Some clinicians prescribe cypionate by a subcutaneous route off-label, which requires explicit instructions for that prescription. The product label establishes the approved route for this particular medicine. An article should not supply a generic injection site, needle choice, or schedule for all products, and a patient should not change routes based on a demonstration of a different formulation.
Gels also differ in strength and application instructions
Testosterone gels vary in concentration, packaging, dose measurement, application areas, and monitoring instructions. A 1% gel and a 1.62% gel are not simply the same product with an adjustable number of pumps. Pumps and packets deliver defined amounts, and substitutions need prescribing or pharmacy clarification.
AndroGel 1.62%, for example, has product-specific application directions and precautions about skin contact. Its prescribing information should be read for that exact product. Do not apply a gel to a different body area or use a previous product’s routine without confirmation. Ask the pharmacist to demonstrate the packaging and explain what to do when a new dispenser is opened or a dose is missed.
Compare the everyday work involved
An injection routine may involve supplies, training, safe handling, storage, and sharps disposal. Some patients administer a prescribed product at home after instruction; others receive it in a clinical setting. The practical plan should fit the actual formulation and the person’s ability to carry it out consistently.
A gel usually involves a regular application routine, drying, handwashing, and precautions to prevent transfer. Showering, swimming, skin contact, and clothing can affect how the directions fit daily life. Neither routine is effortless for everyone. Describe travel, shift work, caregiving, exercise, and household contact before choosing. A formulation that looks convenient on paper may create repeated difficulties in the circumstances where it will actually be used.
Skin transfer is a central gel precaution
Testosterone from treated skin can transfer to another person through contact. The AndroGel label carries a boxed warning about secondary exposure, including reported virilization in children. This is a formulation-specific handling issue that deserves clear instructions before treatment begins, particularly when close contact with children or partners is common.
Follow the exact label’s directions for handwashing, drying, covering the application area, and washing before anticipated skin contact. Ask what to do after accidental exposure and report concerning signs in a household contact. The AndroGel prescribing information provides the detailed precautions. These steps are not a reason to improvise application to an unapproved site; they are part of using the prescribed product correctly.
Injection training should be product-specific
Before home use, obtain training from the prescribing team or another qualified professional. Confirm the concentration, prescribed amount, route, required supplies, and disposal plan. Numbers described as syringe units represent volume markings and should not be confused with the amount of testosterone in milligrams. Concentration changes can make an old volume instruction unsafe.
Use sterile single-use equipment as directed and dispose of sharps in an appropriate container. CDC injection safety guidance and FDA sharps information explain the general principles. Do not share needles, syringes, or medication supplies. If the label and written instructions appear inconsistent, resolve that before administering the product rather than calculating a replacement routine from an online example.
Level patterns and blood-draw timing differ
Testosterone concentrations change over a dosing interval, and the pattern depends on the formulation. With injections, the time since the last dose can substantially affect the interpretation of a blood test. Topical products also require a defined testing approach. A result cannot be judged correctly without knowing the product and collection timing.
The clinician should tell you when to have blood drawn and what dose information to record. Do not compare an injection result obtained at one point in the interval with another person’s gel result as if they represent identical conditions. The AUA guideline discusses formulation-dependent assessment. The purpose of monitoring is appropriate exposure and clinical benefit, not achieving a particular screenshot-worthy number.
Both routes need blood count and blood pressure review
Testosterone can increase hematocrit and blood pressure, so choosing a gel does not eliminate monitoring and choosing an injection does not make adverse effects inevitable. Baseline risks, formulation, exposure, and individual response all matter. Injectable formulations have shown greater increases in hemoglobin and hematocrit in evidence reviewed by the AUA, but comparisons have limitations.
In 2025, the FDA required new or expanded blood-pressure warnings across testosterone products. The FDA announcement applies alongside product-specific instructions. Ask how blood pressure and blood counts will be followed and what findings would prompt reassessment. Our hematocrit article explains why an elevated result needs a clinician’s review rather than routine self-directed blood donation.
Skin and injection-site problems should be reported
Gels can irritate the application area, while injections can cause local discomfort or other site-related problems. Record the location, timing, severity, and whether symptoms are worsening. The clinician can assess whether technique, formulation, an allergic response, infection, or another issue needs attention.
Do not use escalating amounts of a topical product or repeatedly inject through a problematic area to maintain a routine. Significant spreading redness, fever, severe pain, or systemic symptoms need prompt assessment. For a less urgent but persistent problem, contact the practice about alternatives. A different formulation may be appropriate, but switching requires coordinated directions and follow-up rather than independently combining products until symptoms improve.
Storage and travel instructions vary
Do not assume every hormone medicine needs refrigeration. Storage depends on the exact product, and heat, freezing, light, and packaging can matter in different ways. Keep the medication in its labeled container and ask the pharmacist about conditions expected during travel. MedlinePlus medicine-storage guidance provides general principles, while the actual label supplies the temperature requirements.
Alcohol-based gels are flammable until dry; the AndroGel instructions advise avoiding fire, flames, and smoking during that period. For injectable products, plan for safe transport of supplies and sharps disposal. If a medicine has been stored outside its specified conditions, ask the pharmacy whether it remains usable instead of relying on appearance alone.
Switching should address a defined problem
A route change may be considered because of poor adherence, contact concerns, irritation, difficult injections, inadequate response, cost, or an adverse laboratory trend. Explain which problem needs solving and what has already been tried. The new formulation may change monitoring timing and practical instructions as well as the prescription itself.
Confirm when the old product stops and the new one begins. Do not overlap them unless explicitly instructed. At follow-up, assess the original symptoms, correct use, testosterone measurements, blood pressure, blood count, and other relevant safety findings. The side effects and monitoring guide describes this broader review. A successful switch improves the treatment plan as a whole, not just its convenience.
Questions that make the comparison useful
Ask which exact product is proposed, whether the route is on-label or off-label, what training is needed, and how household contact or travel affects use. Clarify blood-draw timing, missed-dose instructions, storage, refill access, and the response to side effects. Also revisit fertility before starting either route.
The first TRT consultation guide helps organize the rest of the decision. The most suitable formulation is one supported by the diagnosis, compatible with the person’s medical history and daily routine, and paired with clear instructions and follow-up. The choice should remain open to reassessment when those circumstances change.
Related reading
- Testosterone Replacement Therapy: Diagnosis, Benefits, and Treatment Options
- TRT Benefits and Results: What to Track Over Time
- TRT and Fertility: Why Testosterone Treatment Can Reduce Sperm Production
- TRT, Muscle, and Body Composition: Hormone Levels Versus Physical Function
- Sermorelin and growth hormone: a different hormone pathway
- Creatine after 50 and strength training
Educational information. Individual treatment selection, prescription directions, and follow-up belong with the treating clinician. Linked guidance and source versions checked September 15, 2026. Medication instructions and evidence can differ by formulation and clinical use. Photographs are illustrative and do not show treatment outcomes.
